CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

budigalimab

mAbexperimental

Clinical trial activity

16 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
8
Phase 2
7
Phase 3
2
Phase 4
0

Earliest trial started Mar 31, 2020 (NCT04306900)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07241039Phase 1Nov 30, 2025AbbVie
NCT06772623Phase 1/Phase 2 (Phase 2)Mar 6, 2025AbbVie
NCT06632951Phase 2Dec 31, 2024AbbVie
NCT06628310Phase 2Dec 8, 2024AbbVie
NCT06487559Phase 1Sep 11, 2024AbbVie
NCT06236438Phase 2/Phase 3 (Phase 3)Apr 10, 2024AbbVie
NCT06158958Phase 1Feb 29, 2024AbbVie
NCT06109272Phase 2/Phase 3 (Phase 3)Jan 16, 2024AbbVie
NCT06119217Phase 2Dec 31, 2023AbbVie, Trishula Therapeutics
NCT06032546Phase 2Oct 12, 2023AbbVie
NCT05822752Phase 2Sep 21, 2023AbbVie
NCT05599984Phase 1Dec 5, 2022AbbVie
NCT05005403Phase 1Nov 1, 2021AbbVie
NCT04807972Phase 2May 28, 2021AbbVie
NCT04799353Phase 1Mar 15, 2021AbbVie
NCT04306900Phase 1Mar 31, 2020AbbVie, Tizona Therapeutics, Inc
Showing 16 of 16 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
AbbVieFor profit161432020
Tizona Therapeutics, IncFor profit1112020
Trishula TherapeuticsFor profit1112023
3 organizations
Page 1 / 1